NONOF
Price
$69.49
Change
+$0.52 (+0.75%)
Updated
Jul 3 closing price
Capitalization
310.37B
UCBJY
Price
$96.19
Change
-$2.08 (-2.12%)
Updated
Jul 3 closing price
Capitalization
37.4B
25 days until earnings call
Interact to see
Advertisement

NONOF vs UCBJY

Header iconNONOF vs UCBJY Comparison
Open Charts NONOF vs UCBJYBanner chart's image
Novo-Nordisk A/S
Price$69.49
Change+$0.52 (+0.75%)
Volume$54.63K
Capitalization310.37B
UCB S.A
Price$96.19
Change-$2.08 (-2.12%)
Volume$16.04K
Capitalization37.4B
NONOF vs UCBJY Comparison Chart in %
Loading...
NONOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UCBJY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NONOF vs. UCBJY commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NONOF is a StrongBuy and UCBJY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (NONOF: $69.49 vs. UCBJY: $96.19)
Brand notoriety: NONOF and UCBJY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NONOF: 46% vs. UCBJY: 34%
Market capitalization -- NONOF: $316.35B vs. UCBJY: $37.78B
NONOF [@Biotechnology] is valued at $316.35B. UCBJY’s [@Biotechnology] market capitalization is $37.78B. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NONOF’s FA Score shows that 2 FA rating(s) are green whileUCBJY’s FA Score has 2 green FA rating(s).

  • NONOF’s FA Score: 2 green, 3 red.
  • UCBJY’s FA Score: 2 green, 3 red.
According to our system of comparison, UCBJY is a better buy in the long-term than NONOF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NONOF’s TA Score shows that 5 TA indicator(s) are bullish while UCBJY’s TA Score has 4 bullish TA indicator(s).

  • NONOF’s TA Score: 5 bullish, 5 bearish.
  • UCBJY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, UCBJY is a better buy in the short-term than NONOF.

Price Growth

NONOF (@Biotechnology) experienced а +4.52% price change this week, while UCBJY (@Biotechnology) price change was -2.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

UCBJY is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NONOF($310B) has a higher market cap than UCBJY($37.4B). UCBJY has higher P/E ratio than NONOF: UCBJY (29.74) vs NONOF (18.71). UCBJY YTD gains are higher at: -1.793 vs. NONOF (-19.101).
NONOFUCBJYNONOF / UCBJY
Capitalization310B37.4B829%
EBITDA147BN/A-
Gain YTD-19.101-1.7931,065%
P/E Ratio18.7129.7463%
Revenue303BN/A-
Total Cash41.6BN/A-
Total Debt119BN/A-
FUNDAMENTALS RATINGS
NONOF vs UCBJY: Fundamental Ratings
NONOF
UCBJY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
3
Undervalued
PROFIT vs RISK RATING
1..100
6626
SMR RATING
1..100
1493
PRICE GROWTH RATING
1..100
6348
P/E GROWTH RATING
1..100
9898
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

UCBJY's Valuation (3) in the null industry is in the same range as NONOF (25). This means that UCBJY’s stock grew similarly to NONOF’s over the last 12 months.

UCBJY's Profit vs Risk Rating (26) in the null industry is somewhat better than the same rating for NONOF (66). This means that UCBJY’s stock grew somewhat faster than NONOF’s over the last 12 months.

NONOF's SMR Rating (14) in the null industry is significantly better than the same rating for UCBJY (93). This means that NONOF’s stock grew significantly faster than UCBJY’s over the last 12 months.

UCBJY's Price Growth Rating (48) in the null industry is in the same range as NONOF (63). This means that UCBJY’s stock grew similarly to NONOF’s over the last 12 months.

UCBJY's P/E Growth Rating (98) in the null industry is in the same range as NONOF (98). This means that UCBJY’s stock grew similarly to NONOF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NONOFUCBJY
RSI
ODDS (%)
Bearish Trend 4 days ago
69%
Bearish Trend 4 days ago
33%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
49%
Momentum
ODDS (%)
Bearish Trend 4 days ago
69%
Bullish Trend 4 days ago
62%
MACD
ODDS (%)
Bearish Trend 4 days ago
70%
Bullish Trend 4 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
54%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
70%
Bullish Trend 4 days ago
67%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 10 days ago
64%
Declines
ODDS (%)
Bearish Trend 11 days ago
60%
Bearish Trend 19 days ago
56%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
53%
Bearish Trend 4 days ago
46%
Aroon
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
NONOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UCBJY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RSCI0.07N/A
N/A
Redwood Scientific Technologies, Inc.
UGDIF0.10N/A
N/A
Unigold Inc.
KPCPF4.60N/A
N/A
KASIKORNBANK Public Co. Ltd.
SCEYF10.51N/A
N/A
Source Energy Services Ltd.
ELTTF89.23N/A
N/A
Elmos Semiconductor AG

NONOF and

Correlation & Price change

A.I.dvisor tells us that NONOF and ATNM have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NONOF and ATNM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NONOF
1D Price
Change %
NONOF100%
+0.75%
ATNM - NONOF
31%
Poorly correlated
+0.70%
NVO - NONOF
31%
Poorly correlated
-0.93%
LABFF - NONOF
23%
Poorly correlated
N/A
UCBJY - NONOF
21%
Poorly correlated
-2.12%
COEP - NONOF
14%
Poorly correlated
+0.80%
More

UCBJY and

Correlation & Price change

A.I.dvisor tells us that UCBJY and SRPT have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that UCBJY and SRPT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UCBJY
1D Price
Change %
UCBJY100%
-2.12%
SRPT - UCBJY
21%
Poorly correlated
+0.25%
DBVT - UCBJY
21%
Poorly correlated
+12.62%
NONOF - UCBJY
20%
Poorly correlated
+0.75%
ZLDPF - UCBJY
13%
Poorly correlated
N/A
TLPPF - UCBJY
13%
Poorly correlated
+4.37%
More